Portfolio Companies 2026 for Gimv: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Gimv accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.3B. The median disclosed raise is $89M, and the largest is Mediar Therapeutics at $181M, ahead of ImCheck Therapeutics ($154M) and JenaValve Technology ($150M).
The names that recur most often on these portfolio cap tables are Gimv (13 companies), Pfizer Ventures (4 companies), Andera Partners (3 companies), EQT Life Sciences (3 companies), Sofinnova Partners (2 companies), Mission BioCapital (2 companies). By latest disclosed round, the market skews Series B (6), Series A (3), Series C (2), IPO (1).
Companies tracked: 13
Disclosed funding total: $1.3B across 13 companies
Median disclosed raise: $89M
Largest raise: Mediar Therapeutics — $181M
Stage mix: Series B 6 · Series A 3 · Series C 2 · IPO 1
